Changchun High-Tech Industry (Group) Co., Ltd. (SHE:000661)

Market Cap	25.23B -40.1%
Revenue (ttm)	11.67B -12.1%
Net Income	-41.99M
EPS	-0.11
Shares Out	401.71M
PE Ratio	n/a
Forward PE	22.30
Dividend	0.16 (0.25%)
Ex-Dividend Date	May 25, 2026

Volume	15,591,610
Open	62.76
Previous Close	62.80
Day's Range	61.09 - 68.49
52-Week Range	61.09 - 141.77
Beta	0.43
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About SHE:000661

Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China. The company offers recombinant human growth hormone injection; recombinant human follicle stimulating hormone for injection; herpes zoster vaccines; live attenuated varicella vaccine; freeze-dried nasal spray live attenuated influenza; xueshuanxinmaining tablet; and yinhuamiyanling tablet. It also develops real estate properties. The company was foun...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 10,080
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000661

Financial Performance

In 2025, SHE:000661's revenue was 12.08 billion, a decrease of -10.27% compared to the previous year's 13.47 billion. Earnings were 154.97 million, a decrease of -94.00%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 29, 2026

Data Sources Report a data error